← Back to Search

Fatty Acid Supplement

C15:0 Supplementation for Metabolic Syndrome in Young Adults

N/A

Waitlist Available

Led By Jeffrey Schwimmer, MD

Research Sponsored by Jeffrey B. Schwimmer, MD

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Be between 18 and 65 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up baseline to 12 weeks

Awards & highlights

Study Summary

This trial will see if adding a type of saturated fat to one's diet affects their BMI.

Eligible Conditions

Metabolic Syndrome

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ baseline to 12 weeks

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~baseline to 12 weeks

This trial's timeline: 3 weeks for screening, Varies for treatment, and baseline to 12 weeks for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Change in plasma C15:0 levels

Secondary outcome measures

Change in BMI

Change in High Sensitivity C-reactive protein

Change in Weight

+10 more

Trial Design

2Treatment groups

Active Control

Placebo Group

Group I: ActiveActive Control1 Intervention

200mg of pentadecanoic acid (C15:0) supplementation in capsules form

Group II: PlaceboPlacebo Group1 Intervention

Matching placebo in capsules form

Do I qualify?Apply below to find out

Find a Location

Who is running the clinical trial?

Jeffrey B. Schwimmer, MDLead Sponsor

Jeffrey Schwimmer, MDPrincipal InvestigatorUC San Diego

1 Previous Clinical Trials

20 Total Patients Enrolled

Media Library

Supplement (Fatty Acid Supplement) Clinical Trial Eligibility Overview. Trial Name: NCT04947176 — N/A

Metabolic Syndrome Research Study Groups: Active, Placebo

Metabolic Syndrome Clinical Trial 2023: Supplement Highlights & Side Effects. Trial Name: NCT04947176 — N/A

Supplement (Fatty Acid Supplement) 2023 Treatment Timeline for Medical Study. Trial Name: NCT04947176 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Am I eligible to be an experimental subject in this research study?

"This research endeavour is seeking 30 study candidates aged between 18 and 25 years old who have been diagnosed with metabolic syndrome. Moreover, the Body Mass Index of all applicants must be equal to or greater than 25 Kg/m2."

Answered by AI

What is the total number of participants in this research endeavor?

"Affirmative. Clinicaltrials.gov's records suggest that, since its initial posting on July 6th 2021, this clinical study has been actively recruiting patients; presently seeking 30 participants from a single centre."

Answered by AI

Is there availability for participants in this trial?

"Per the information on clinicaltrials.gov, patient recruitment for this trial is ongoing and started 7/6/2021. The last time any changes were made to the study was 5/4/2022."

Answered by AI

Is this medical experiment accepting volunteers younger than seventy-five years of age?

"The minimum age of consent has been established as the lower limit for this experiment; correspondingly, participants must be no older than 25 years old. Separately, there are 383 and 1045 trials respectively dedicated to minors and seniors."

Answered by AI

Recent research and studies

clinicaltrials.govStudy

C15:0 Supplementation in Young Adults at Risk for Metabolic Syndrome

Jeffrey B. Schwimmer, MD 2021. "C15:0 Supplementation in Young Adults at Risk for Metabolic Syndrome". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT04947176.

All > Metabolic Syndrome